The Tufts Center for the Study of Drug Development (CSDD) published its Outlook 2013 report on pharmaceutical trends. Although Tufts CSDD Director Kenneth I Kaitlin is optimistic about the future of dug innovation, he believes companies needs to identify and reduce...
In an article on MedPage.com, Senior Editor John Gever reviews a recent study published in Science by Yaniv Erlich, of the Whitehead Institute for Biomedical Research in Cambridge, Mass., and colleague. Erlich and colleagues were able to identify the full names of 5...
The Annals of Internal Medicine published a guideline, entitled “The Standard Protocol Items: Recommendations for Interventional Trials” or SPIRIT 2013 to address the clinical practice quality issues surrounding current trials, as reported by an article on...
A recent article from mobihealthnews.com describes how technology is helping streamline clinical trials by bridging communication between investigators, pharmaceutical companies and participants. Communication between companies and third party investigators is often a...
A recent post from MedPage Today describes the newly published FDA draft guidance entitled “Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products” that will potentially improve the speed of drug development. The guidance...
